Pacira BioSciences, Inc. Quarterly Goodwill in USD from Q4 2011 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
Summary
Pacira BioSciences, Inc. quarterly Goodwill history and growth rate from Q4 2011 to Q3 2024.
  • Pacira BioSciences, Inc. Goodwill for the quarter ending September 30, 2024 was $0.000, a 100% decline year-over-year.
Goodwill, Quarterly (USD)
Goodwill, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $0 -$163M -100% Sep 30, 2024 10-Q 2024-11-06
Q2 2024 $163M $0 0% Jun 30, 2024 10-Q 2024-07-30
Q1 2024 $163M $0 0% Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $163M $0 0% Dec 31, 2023 10-Q 2024-11-06
Q3 2023 $163M +$5.88M +3.74% Sep 30, 2023 10-Q 2023-11-02
Q2 2023 $163M +$17.1M +11.7% Jun 30, 2023 10-Q 2023-08-02
Q1 2023 $163M +$17.5M +12% Mar 31, 2023 10-Q 2023-05-03
Q4 2022 $163M +$18M +12.4% Dec 31, 2022 10-K 2024-02-29
Q3 2022 $157M +$57.8M +58.1% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 $146M +$46.6M +46.8% Jun 30, 2022 10-Q 2022-08-03
Q1 2022 $146M +$46.2M +46.4% Mar 31, 2022 10-Q 2022-05-04
Q4 2021 $145M +$45.7M +45.9% Dec 31, 2021 10-K 2024-02-29
Q3 2021 $99.5M $0 0% Sep 30, 2021 10-Q 2021-11-03
Q2 2021 $99.5M $0 0% Jun 30, 2021 10-Q 2021-08-03
Q1 2021 $99.5M $0 0% Mar 31, 2021 10-Q 2021-05-04
Q4 2020 $99.5M $0 0% Dec 31, 2020 10-K 2023-02-28
Q3 2020 $99.5M $0 0% Sep 30, 2020 10-Q 2020-10-30
Q2 2020 $99.5M -$991K -0.99% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 $99.5M +$37.5M +60.5% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 $99.5M +$37.5M +60.5% Dec 31, 2019 10-K 2022-02-28
Q3 2019 $99.5M +$37.5M +60.5% Sep 30, 2019 10-Q 2019-11-08
Q2 2019 $101M +$40.6M +67.8% Jun 30, 2019 10-Q 2019-08-08
Q1 2019 $62M +$4.55M +7.91% Mar 31, 2019 10-Q 2019-05-02
Q4 2018 $62M +$6.84M +12.4% Dec 31, 2018 10-K 2021-03-01
Q3 2018 $62M +$9.08M +17.2% Sep 30, 2018 10-Q 2018-11-01
Q2 2018 $59.9M +$8.97M +17.6% Jun 30, 2018 10-Q 2018-08-02
Q1 2018 $57.5M +$8.66M +17.7% Mar 31, 2018 10-Q 2018-05-03
Q4 2017 $55.2M +$8.46M +18.1% Dec 31, 2017 10-K 2020-02-21
Q3 2017 $53M +$8.29M +18.5% Sep 30, 2017 10-Q 2017-11-08
Q2 2017 $50.9M +$8.19M +19.2% Jun 30, 2017 10-Q 2017-08-02
Q1 2017 $48.8M +$16M +48.9% Mar 31, 2017 10-Q 2017-05-04
Q4 2016 $46.7M +$15.9M +51.4% Dec 31, 2016 10-K 2019-02-28
Q3 2016 $44.7M +$15.8M +54.6% Sep 30, 2016 10-Q 2016-11-02
Q2 2016 $42.8M +$15.6M +57.6% Jun 30, 2016 10-Q 2016-08-04
Q1 2016 $32.8M +$7.4M +29.2% Mar 31, 2016 10-Q 2016-05-02
Q4 2015 $30.9M +$7.12M +30% Dec 31, 2015 10-K 2018-02-28
Q3 2015 $28.9M +$6.84M +31% Sep 30, 2015 10-Q 2015-10-27
Q2 2015 $27.1M +$14.6M +117% Jun 30, 2015 10-Q 2015-07-30
Q1 2015 $25.4M +$14.1M +124% Mar 31, 2015 10-Q 2015-04-30
Q4 2014 $23.8M +$13.4M +130% Dec 31, 2014 10-K 2017-03-01
Q3 2014 $22M +$12.5M +131% Sep 30, 2014 10-Q 2014-10-30
Q2 2014 $12.5M +$3.54M +39.4% Jun 30, 2014 10-Q 2014-07-31
Q1 2014 $11.3M +$2.75M +32% Mar 31, 2014 10-Q 2014-05-01
Q4 2013 $10.3M +$2.03M +24.5% Dec 31, 2013 10-K 2016-02-25
Q3 2013 $9.54M +$1.43M +17.6% Sep 30, 2013 10-Q 2013-10-31
Q2 2013 $8.98M +$988K +12.4% Jun 30, 2013 10-Q 2013-08-06
Q1 2013 $8.58M +$582K +7.28% Mar 31, 2013 10-Q 2013-05-08
Q4 2012 $8.3M +$8.3M Dec 31, 2012 10-K 2015-02-24
Q3 2012 $8.11M Sep 30, 2012 10-Q 2012-11-01
Q2 2012 $7.99M Jun 30, 2012 10-Q 2012-08-09
Q1 2012 $8M Apr 30, 2012 10-Q 2018-08-02
Q4 2011 $0 Dec 31, 2011 10-K 2014-02-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.